These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35965420)

  • 1. Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia.
    Ren X; Tao Q; Wang H; Zhang Q; Zhou M; Liu L; Zhai Z
    Turk J Haematol; 2022 Dec; 39(4):230-236. PubMed ID: 35965420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia.
    Wang H; Tao Q; Wang Z; Zhang Q; Xiao H; Zhou M; Dong Y; Zhai Z
    J Immunol Res; 2020; 2020():7363084. PubMed ID: 33415170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Levels of Circulating Monocytic- and Early-Stage Myeloid-Derived Suppressor Cells (MDSC) in Acute Myeloid Leukemia.
    Lv J; Zhao Y; Zong H; Ma G; Wei X; Zhao Y
    Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.
    Jitschin R; Saul D; Braun M; Tohumeken S; Völkl S; Kischel R; Lutteropp M; Dos Santos C; Mackensen A; Mougiakakos D
    J Immunother Cancer; 2018 Nov; 6(1):116. PubMed ID: 30396365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
    Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
    Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience.
    Zahran AM; Moeen SM; Thabet AF; Rayan A; Abdel-Rahim MH; Mohamed WMY; Hetta HF
    Leuk Lymphoma; 2020 Jul; 61(7):1645-1652. PubMed ID: 32077360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial absolute monocyte count as an immune biomarker for clinical response in acute myeloid leukemia with monocytic differentiation.
    Embaby A; Fathy A; Al-Akkad M; Baraka A; Ibrahim T; Zidan N; Refaat M; Elsheikh H
    J Egypt Natl Canc Inst; 2020 Aug; 32(1):33. PubMed ID: 32743788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia.
    Sun H; Li Y; Zhang ZF; Ju Y; Li L; Zhang BC; Liu B
    Int J Hematol; 2015 Nov; 102(5):579-86. PubMed ID: 26358057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling.
    Tohumeken S; Baur R; Böttcher M; Stoll A; Loschinski R; Panagiotidis K; Braun M; Saul D; Völkl S; Baur AS; Bruns H; Mackensen A; Jitschin R; Mougiakakos D
    Cancer Res; 2020 Sep; 80(17):3663-3676. PubMed ID: 32605996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells.
    Urakawa S; Yamasaki M; Goto K; Haruna M; Hirata M; Morimoto-Okazawa A; Kawashima A; Iwahori K; Makino T; Kurokawa Y; Yamada T; Mori M; Doki Y; Wada H
    Cancer Immunol Immunother; 2019 Aug; 68(8):1341-1350. PubMed ID: 31324947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2).
    Soler DC; Kerstetter-Fogle A; Young AB; Rayman P; Finke JH; Debanne SM; Cooper KD; Barnholtz-Sloan J; Sloan AE; McCormick TS
    Mol Immunol; 2022 Feb; 142():1-10. PubMed ID: 34953280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
    Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W
    Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive role of CD11b
    Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
    Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral levels of monocytic myeloid-derived suppressive cells before and after first induction predict relapse and survivals in AML patients.
    Peterlin P; Debord C; Eveillard M; Garnier A; Le Bourgeois A; Guillaume T; Jullien M; Béné MC; Chevallier P
    J Cell Mol Med; 2022 Nov; 26(21):5486-5492. PubMed ID: 36226545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.
    Xing YF; Cai JR; Qin JJ; Zhou WY; Li CM; Li X
    Front Immunol; 2020; 11():577253. PubMed ID: 33584644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of initial absolute monocyte count on survival outcome of patients with de novo non-M3 acute myeloid leukemia.
    Feng J; Zhang W; Wu J; Gao S; Ye H; Sun L; Chen Y; Yu K; Xing CY
    Leuk Lymphoma; 2016 Nov; 57(11):2548-54. PubMed ID: 27074049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression.
    Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of absolute monocyte count post-transplant on the outcome of patients with acute myeloid leukemia undergoing myeloablative allogeneic hematopoietic stem cell transplant with busulfan and cyclophosphamide conditioning.
    Tang L; Wang N; Xing C; Zhuang Q; Liang B; Sun L; Chen Y; Qian Y; Shen Z; Jiang S; Yu K; Feng J
    Leuk Res; 2018 Jun; 69():60-65. PubMed ID: 29660493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocytic and Monocytic Myeloid-Derived Suppressor Cells are Functionally and Prognostically Different in Patients with Chronic Myeloid Leukemia.
    Ahn A; Park CJ; Kim MS; Cho YU; Jang S; Bae MH; Lee JH; Lee JH; Koh KN; Im HJ
    Ann Lab Med; 2021 Sep; 41(5):479-484. PubMed ID: 33824236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.